HTX-034

· Heron Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HTX-034, covering 2022-02-15 to 2026-06-09. Get the full timeline:

Most recent: Clinical Trial Results: Dose-Escalation Study of HTX-034 Following Bunionectomy [Phase 1, Phase 2]